https://www.selleckchem.com/pr....oducts/1-methylnicot
Patients receiving surgery (HR = 0.33, p 0.0001), chemotherapy (HR = 0.71, p = 0.006), and endocrine therapy (HR = 0.61, p 0.0001) had better OS compared to those who did not receive these treatments. Despite serving a vulnerable minority population that is largely poor, uninsured, and presenting with more advanced disease, OS at our SNH approaches national averages. This novel finding indicates that in the setting of multidisciplinary cancer care and with appropriate initiation of treatment, SNHs can ove
Like
Comment
Share
